StocksMedium•5 November 2026•
1 min read
Agios Pharmaceuticals Reports Narrower-Than-Expected Q3 Loss
Key Facts
1Agios Pharmaceuticals reported a quarterly loss of $1.09 per share, narrower than the estimated loss of $1.32.
2The results show a significant improvement from a loss of $1.78 per share reported a year ago.
Agios Pharmaceuticals reported a quarterly loss of $1.09 per share for the third quarter of 2026. Zacks reported that the result was narrower than the estimated loss of $1.32 per share, representing a beat against analyst consensus.
The results indicate a significant improvement from the prior year's loss of $1.78 per share. AGIO closed at $31.38 on November 4, 2026, having traded between a low of $30.56 and a high of $32.09 during that session.